Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology

被引:2
作者
Lin, Xiaoqi [1 ,2 ]
机构
[1] Northwestern Univ, Dept Pathol, Chicago, IL USA
[2] Northwestern Univ, Northwestern Mem Hosp, Feinberg Sch Med, Dept Pathol, 251 E Huron St,Galter Pavilion 7-132F, Chicago, IL 60611 USA
关键词
clear cell papillary renal cell tumour; core needle biopsy; cytopathology; immunohistochemistry; molecular test; renal cell carcinoma; touch preparation; FEATURES;
D O I
10.1111/cyt.13384
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
BackgroundClear cell papillary renal cell tumour (CCPRCT) was renamed from previous clear cell papillary renal cell carcinoma (CCPRCC) in the latest WHO Classification of Tumours. It is essential to differentiate RCC from CCPRCT in renal mass biopsies (RMB).DesignRMB cases with subsequent resections were reviewed. The pathology reports and pertinent clinical information were recorded.ResultsFifteen cases displaying either CCPRCT morphology (20% diffuse, 67% focal) or immunohistochemical patterns (cup-like CA9: 20% diffuse, 47% focal; CK7: 33% diffuse, 40% focal) were identified. One case was positive for TFE3. TSC mutation was identified in one case. Both cases exhibited both CCPRCT morphology and immunohistochemical patterns for CA9 and CK7, with focal high-grade nuclei. RMB diagnoses were as follows: 6 (40%) as CCRCC, 2 (13%) as CCPRCT, 2 (13%) as CCRCC versus CCPRCT, 2 (13%) as CCRCC versus PRCC, 1 (7%) as RCC with TSC mutation versus CCPRCT, 1 (7%) as TFE3-rearranged RCC versus PRCC, and 1 (7%) as cyst with low-grade atypia. 71% of patients underwent nephrectomy, 21% received systemic treatment for stage 4 RCCs, and 7% with ablation for small renal mass (1.6 cm) with low-grade CCRCC.ConclusionsOur study highlights that morphologic and immunochemical features of CCPRCT may be present in RCCs, including RCC-TFE3 expression and TSC-associated RCC, a critical pitfall to misdiagnose aggressive RCC as indolent CCPRCT and result in undertreatment. Careful examination of morphology and immunostains for CA9, CK7, and TFE3, as well as molecular tests, is crucial for distinguishing aggressive RCC from indolent CCPRCT. The characteristic morphology and immunohistochemical patterns observed in CCPRCT can also manifest in RCC. It is crucial to distinguish indolent CCPRCT from more biologically aggressive forms of RCC for the improvement of patients' management.image
引用
收藏
页码:481 / 487
页数:7
相关论文
共 16 条
  • [11] Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting
    Kapur, Payal
    Brugarolas, James
    Trpkov, Kiril
    [J]. CANCERS, 2023, 15 (16)
  • [12] Cytomorphology of Clear Cell Papillary Renal Cell Carcinoma
    Lin, Xiaoqi
    [J]. CANCER CYTOPATHOLOGY, 2017, 125 (01) : 48 - 54
  • [13] GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics
    Mantilla, Jose G.
    Antic, Tatjana
    Tretiakova, Maria
    [J]. HUMAN PATHOLOGY, 2017, 66 : 152 - 158
  • [14] Nair Nikhil, 2020, J Kidney Cancer VHL, V7, P5, DOI 10.15586/jkcvhl.2020.131
  • [15] Cytopathologic features of clear cell papillary renal cell carcinoma: A recently described variant to be considered in the differential diagnosis of clear cell renal epithelial neoplasms
    Sayeed, Sadia
    Lindsey, Kathryn G.
    Baras, Alexander S.
    Jackson, Christopher
    Powers, Celeste N.
    Uram-Tuculescu, Cora
    Smith, Steven C.
    [J]. CANCER CYTOPATHOLOGY, 2016, 124 (08) : 565 - 572
  • [16] Renal Cell Carcinoma in Tuberous Sclerosis Complex
    Yang, Ping
    Cornejo, Kristine M.
    Sadow, Peter M.
    Cheng, Liang
    Wang, Mingsheng
    Xiao, Yu
    Jiang, Zhong
    Oliva, Esther
    Jozwiak, Sergiusz
    Nussbaum, Robert L.
    Feldman, Adam S.
    Paul, Elahna
    Thiele, Elizabeth A.
    Yu, Jane J.
    Henske, Elizabeth P.
    Kwiatkowski, David J.
    Young, Robert H.
    Wu, Chin-Lee
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (07) : 895 - 909